These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30808023)

  • 1. Major Pathologic Response after Induction Therapy Has a Long-Term Impact on Survival and Tumor Recurrence in Stage IIIA/B Locally Advanced NSCLC.
    Schreiner W; Dudek W; Rieker RJ; Lettmaier S; Fietkau R; Sirbu H
    Thorac Cardiovasc Surg; 2020 Oct; 68(7):639-645. PubMed ID: 30808023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction chemoradiotherapy is superior to induction chemotherapy for the survival of non-small-cell lung cancer patients with pathological mediastinal lymph node metastasis.
    Toyooka S; Kiura K; Shien K; Katsui K; Hotta K; Kanazawa S; Date H; Miyoshi S
    Interact Cardiovasc Thorac Surg; 2012 Dec; 15(6):954-60. PubMed ID: 22976995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoradiation Therapy Followed by Surgery in the Treatment of Locoregionally Advanced Non-Small Cell Lung Cancer.
    Cohen C; Pop D; Venissac N; Poudenx M; Otto J; Castelnau O; Mouroux J
    Thorac Cardiovasc Surg; 2018 Mar; 66(2):129-134. PubMed ID: 28992652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of Patients With pN2 "Potentially Resectable" Nonsmall Cell Lung Cancer Who Underwent Surgery After Induction Chemotherapy.
    Spaggiari L; Casiraghi M; Guarize J; Brambilla D; Petrella F; Maisonneuve P; De Marinis F
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):593-602. PubMed ID: 28043483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Survival after Salvage Surgery for Local Failure after Definitive Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer.
    Schreiner W; Dudek W; Lettmaier S; Fietkau R; Sirbu H
    Thorac Cardiovasc Surg; 2018 Mar; 66(2):135-141. PubMed ID: 28992654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of proliferative indices in surgically resected IIIA-N2 non-small cell lung cancer after induction chemotherapy.
    Corzani R; Luzzi L; Spina D; Voltolini L; Paladini P; Ghiribelli C; Ghisalberti M; Borrelli R; Meniconi F; Monaci N; Gotti G
    J Cardiovasc Surg (Torino); 2017 Oct; 58(5):763-769. PubMed ID: 24740119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment modalities in Pancoast tumor: results of a monocentric retrospective study.
    Jeannin G; Merle P; Janicot H; Thibonnier L; Kwiatkowski F; Naame A; Chadeyras JB; Galvaing G; Belliere A; Filaire M; Verrelle P
    Chin Clin Oncol; 2015 Dec; 4(4):39. PubMed ID: 26730751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment: Only few risks left to improve.
    Guberina N; Pöttgen C; Schuler M; Guberina M; Stamatis G; Plönes T; Krebs B; Metzenmacher M; Theegarten D; Gauler T; Jöckel KH; Darwiche K; Aigner C; Stuschke M; Eberhardt WE
    Eur J Cancer; 2020 Oct; 138():156-168. PubMed ID: 32889370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer.
    Gao SJ; Corso CD; Wang EH; Blasberg JD; Detterbeck FC; Boffa DJ; Decker RH; Kim AW
    J Thorac Oncol; 2017 Feb; 12(2):314-322. PubMed ID: 27720827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemoradiotherapy followed by surgery for stage IIIa and IIIb non-small-cell lung cancer (NSCLC): is it still justified?
    Mirimanoff RO
    Chin Clin Oncol; 2015 Dec; 4(4):49. PubMed ID: 26730761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysis.
    Brandt WS; Yan W; Zhou J; Tan KS; Montecalvo J; Park BJ; Adusumilli PS; Huang J; Bott MJ; Rusch VW; Molena D; Travis WD; Kris MG; Chaft JE; Jones DR
    J Thorac Cardiovasc Surg; 2019 Feb; 157(2):743-753.e3. PubMed ID: 30415902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.
    Marulli G; Verderi E; Zuin A; Schiavon M; Battistella L; Perissinotto E; Romanello P; Favaretto AG; Pasello G; Rea F
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):256-62; discussion 262. PubMed ID: 24824495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimodality vs Chemoradiation and Salvage Resection in cN2 Stage IIIA Non-Small Cell Lung Cancer.
    Ye JC; Ding L; Atay SM; Nieva JJ; McFadden PM; Chang E; Kim AW
    Semin Thorac Cardiovasc Surg; 2020; 32(1):153-159. PubMed ID: 31220530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lung Resection after Definitive and Neo-Adjuvant Chemoradiation for Stage IIIA/B Locally Advanced Non-Small Cell Lung Cancer: a Retrospective Analysis].
    Schreiner W; Gavrychenkova S; Dudek W; Lettmaier S; Rieker R; Fietkau R; Sirbu H
    Zentralbl Chir; 2018 Jun; 143(3):307-315. PubMed ID: 29933483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neo-adjuvant Chemo-Radiation to 60 Gray Followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer Patients: Evaluation of Trimodality Strategy.
    Appel S; Goldstein J; Perelman M; Rabin T; Urban D; Onn A; Shulimzon TR; Weiss I; Lieberman S; Marom EM; Golan N; Simansky D; Ben-Nun A; Lawrence YR; Bar J; Symon Z
    Isr Med Assoc J; 2017 Oct; 19(10):614-619. PubMed ID: 29103238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Density of tumor-infiltrating FOXP3+ T cells as a response marker for induction chemoradiotherapy and a potential prognostic factor in patients treated with trimodality therapy for locally advanced non-small cell lung cancer.
    Tao H; Shien K; Soh J; Matsuda E; Toyooka S; Okabe K; Miyoshi S
    Ann Thorac Cardiovasc Surg; 2014; 20(6):980-6. PubMed ID: 24583705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Patients Unable to Undergo Adjuvant Chemotherapy after Surgery in Stage IIIA/B Non-Small Cell Lung Cancer: Will They Benefit from Mediastinal Radiotherapy?
    Graeter TP; Sebastian B; Bischof M; Kugler G; Fischer JR; Schneider T
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):501-6. PubMed ID: 26322832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity and mortality after major pulmonary resections in patients with locally advanced stage IIIA non-small cell lung carcinoma who underwent induction therapy.
    Peer M; Stav D; Cyjon A; Sandbank J; Vasserman M; Haitov Z; Sasson L; Schreiber L; Ezri T; Priel IE; Hayat H
    Heart Lung Circ; 2015 Jan; 24(1):69-76. PubMed ID: 25086910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Surgery after Chemoradiotherapy Feasible in Lung Cancer Patients with Superior Vena Cava Invasion?
    Sato H; Soh J; Hotta K; Katsui K; Kanazawa S; Kiura K; Toyooka S
    Ann Thorac Cardiovasc Surg; 2018 Jun; 24(3):131-138. PubMed ID: 29681596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.